Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

The purpose of this study was to gain more insight into the mechanism of action of pasireotide in patients who completed the PAOLA study. PAOLA was a 24-week, Phase III, randomized, three-arm study of pasireotide LAR 40 and 60 mg versus octreotide LAR 30 mg or lanreotide Autogel 120 mg in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmid, Herbert A., Brue, Thierry, Colao, Annamaria, Gadelha, Mônica R., Shimon, Ilan, Kapur, Karen, Pedroncelli, Alberto M., Fleseriu, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901125/
https://www.ncbi.nlm.nih.gov/pubmed/26906713
http://dx.doi.org/10.1007/s12020-016-0895-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901125/
https://www.ncbi.nlm.nih.gov/pubmed/26906713
http://dx.doi.org/10.1007/s12020-016-0895-8

Ejemplares similares